Published in Neuroimage on October 15, 2008
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun (2014) 1.44
Action and therapeutic potential of oxyntomodulin. Mol Metab (2013) 0.98
Obesity treatment: novel peripheral targets. Br J Clin Pharmacol (2009) 0.95
The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin. Obesity (Silver Spring) (2012) 0.90
Unraveling oxyntomodulin, GLP1's enigmatic brother. J Endocrinol (2012) 0.88
Neuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite. J Neuroendocrinol (2010) 0.87
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists. Rev Diabet Stud (2009) 0.85
Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity. Diabetes Care (2013) 0.85
Differential effects of two fermentable carbohydrates on central appetite regulation and body composition. PLoS One (2012) 0.84
Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice. PLoS One (2009) 0.83
Gut hormones: the future of obesity treatment? Br J Clin Pharmacol (2012) 0.78
Bowels control brain: gut hormones and obesity. Biochem Med (Zagreb) (2012) 0.77
Nutrition and L and K-enteroendocrine cells. Curr Opin Endocrinol Diabetes Obes (2011) 0.76
Effect of manganese chloride on the neurochemical profile of the rat hypothalamus. J Cereb Blood Flow Metab (2011) 0.76
Role of gastrointestinal hormones in feeding behavior and obesity treatment. J Gastroenterol (2015) 0.75
Review of the neuroanatomic landscape implicated in glucose sensing and regulation of nutrient signaling: immunophenotypic localization of diabetes gene Tcf7l2 in the developing murine brain. J Chem Neuroanat (2012) 0.75
Depressed basal hypothalamic neuronal activity in type-1 diabetic mice is correlated with proinflammatory secretion of HMBG1. Neurosci Lett (2016) 0.75
Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption. Psychopharmacology (Berl) (2014) 0.75
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int (2009) 4.61
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem (2004) 3.84
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab (2005) 3.08
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg (2007) 3.02
Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53
Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment. Pediatrics (2006) 2.43
The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest (2005) 2.40
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes (2003) 2.28
Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab (2006) 2.23
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res (2005) 2.19
Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J (2005) 2.03
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut (2013) 2.01
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.97
Gastric bypass increases energy expenditure in rats. Gastroenterology (2009) 1.79
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int (2009) 1.78
An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology (2008) 1.76
Fasting biases brain reward systems towards high-calorie foods. Eur J Neurosci (2009) 1.74
Magic angle effects in MR neurography. AJNR Am J Neuroradiol (2004) 1.73
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70
Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol (2007) 1.61
Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons. Cell Metab (2009) 1.59
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest (2014) 1.58
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica (2009) 1.49
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology (2005) 1.49
Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience. Radiology (2006) 1.49
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology (2006) 1.49
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays. Clin Endocrinol (Oxf) (2012) 1.47
Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab (2007) 1.46
Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol (2011) 1.44
The influence of maternal body mass index on infant adiposity and hepatic lipid content. Pediatr Res (2011) 1.41
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg (2010) 1.39
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab (2005) 1.38
Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab (2009) 1.38
Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev (2006) 1.38
Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet (2002) 1.36
Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 1.35
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab (2011) 1.35
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol (2002) 1.33
The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) (2011) 1.33
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg (2010) 1.32
Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology (2004) 1.31
Magnetic resonance imaging of the knee with ultrashort TE pulse sequences. Magn Reson Imaging (2004) 1.30
Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology (2004) 1.30
Gastrointestinal satiety signals. Annu Rev Physiol (2008) 1.27
Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab (2006) 1.26
The role of gut hormones and the hypothalamus in appetite regulation. Endocr J (2010) 1.24
Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol (2010) 1.23
Whole body magnetic resonance imaging of healthy newborn infants demonstrates increased central adiposity in Asian Indians. Pediatr Res (2009) 1.22
The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci (2003) 1.22
Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol (2006) 1.21
Impact of resistant starch on body fat patterning and central appetite regulation. PLoS One (2007) 1.20
Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology (2012) 1.20
Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg (2010) 1.20
Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr (2007) 1.19
Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol (2005) 1.18
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity. Gut Liver (2012) 1.16
Gut hormones and the control of appetite. Trends Endocrinol Metab (2004) 1.15
Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab (2005) 1.14